Overview
- The research, published on Tuesday, June 30, 2026, reports laboratory validation of a composite dressing and describes plans by the team to file a patent and seek industry partners for clinical trials.
- The dressing pairs a chitosan-coated cotton gauze with an electrospun nanofibrous layer that sits between the wound and the gauze to prevent direct contact and reduce adhesion.
- The nanofibrous layer is loaded with curcumin, a natural antimicrobial, and laboratory tests showed sustained curcumin release, reduced wound sticking, and support for cell growth compared with conventional gauze.
- No clinical trial results or commercial product exist yet, and the researchers describe patenting and industry collaboration as the next steps before regulatory testing and market rollout.
- The team projects a modest price rise if made commercially, estimating about INR 50–60 for a 10 cm × 4 m roll versus about INR 30 for standard gauze, which could mean less pain, fewer infections, and lower treatment needs for patients who require frequent dressing changes.